NL
DE
4 February 2020
The, in total 12, awarded projects will jointly receive over nine million euros from this first round of the ZonMw Open Competition. This programme aims to create opportunities for outstanding curiosity-driven (groundbreaking) research. The funding enables excellent research groups to renew their research lines that contribute to health research. Another important requirement is that they realize new collaborations between various research groups.
Awarded projects:
Michiel Vermeulen
Defining H3K9 methylation regulatory pathways in monocyte and macrophage function in cardiovascular disease
More information about this project will follow soon.
Jolanda de Vries, Gerty Schreibelt and Martijn Verdoes
Optimizing the design of dendritic cell vaccine immunotherapies
In recent years, vaccination has sprouted as an extremely promising new therapeutic strategy to combat cancer. Many clinical trials are based on the vaccination of cancer patients with peptides corresponding to cancer antigens with the aim of raising anti-cancer cytolytic T lymphocytes (CTL) responses. The efficacy of immune vaccines depends on how effective the peptide is cross-presented by dendritic cells (DCs) to activate CTLs. Goal of this project is to optimize the cross-presentation efficiency of cancer-specific MHC-I-binding epitopes by chemical modifications. We propose to unravel the cell-biological basis of cross-presentation of different antigen vaccine modalities by a combination of novel chemical approaches with state-of-the- art cell biology, microscopy and immunology. We envision that this study will lead to a universal strategy for designing optimal peptide-based anti-cancer vaccines. This novel directed approach will lead to a detailed understanding of CTL cross-priming and thereby allow for smart design strategies to optimize anti-cancer vaccination.
More information: link.
The, in total 12, awarded projects will jointly receive over nine million euros from this first round of the ZonMw Open Competition. This programme aims to create opportunities for outstanding curiosity-driven (groundbreaking) research. The funding enables excellent research groups to renew their research lines that contribute to health research. Another important requirement is that they realize new collaborations between various research groups.
Awarded projects:
Michiel Vermeulen
Defining H3K9 methylation regulatory pathways in monocyte and macrophage function in cardiovascular disease
More information about this project will follow soon.
Jolanda de Vries, Gerty Schreibelt and Martijn Verdoes
Optimizing the design of dendritic cell vaccine immunotherapies
In recent years, vaccination has sprouted as an extremely promising new therapeutic strategy to combat cancer. Many clinical trials are based on the vaccination of cancer patients with peptides corresponding to cancer antigens with the aim of raising anti-cancer cytolytic T lymphocytes (CTL) responses. The efficacy of immune vaccines depends on how effective the peptide is cross-presented by dendritic cells (DCs) to activate CTLs. Goal of this project is to optimize the cross-presentation efficiency of cancer-specific MHC-I-binding epitopes by chemical modifications. We propose to unravel the cell-biological basis of cross-presentation of different antigen vaccine modalities by a combination of novel chemical approaches with state-of-the- art cell biology, microscopy and immunology. We envision that this study will lead to a universal strategy for designing optimal peptide-based anti-cancer vaccines. This novel directed approach will lead to a detailed understanding of CTL cross-priming and thereby allow for smart design strategies to optimize anti-cancer vaccination.
More information: link.
Related news items
ZonMw Open Competition Grant for Annemiek van Spriel and Piet Gros
15 June 2021 Annemiek van Spriel, theme cancer development and immune defense, together with Piet Gros, Dept. of Chemistry, Utrecht University obtained a ZonMw Open Competition Grant to investigate IL-6 receptor structure and signalling in tumor cells. read more
HFSP Grant for Johannes Textor
30 March 2020 Johannes Textor, theme Cancer development and immune defense, has been awarded a program grant of 1 million US dollars by The Human Frontier Science Program (HFSP) to investigate how T cells navigate extremely dense environments using experiments, modeling and methods from pedestrian dynamics. read more
Human pDCs attract cytolytic lymphocytes in anti-cancer vaccination
6 February 2020 RIMLS researchers Jasper van Beek and Jolanda de Vries, theme Cancer development and immune defense, discovered that pDCs can efficiently recruit cytolytic immune effector cells, a property that could be exploited in anti-cancer vaccines. They have published these findings in Cell Reports. read more
Niels Stensen Fellowship for Jorieke Weiden
6 January 2020 Jorieke Weiden was recently awarded a grant from the Niels Stensen Fellowship. Since the 1960s, the Niels Stensen Fellowship has been awarded annually to outstanding researchers who recently received their PhD to enable them to gain research experience at a top university or institute abroad. read more
Galectin-9 controls plasma membrane integrity of dendritic cells
16 December 2019 Laia Querol Cano, theme Cancer development and immune defense, has discovered how galectin-9, a sugar-binding membrane organiser, governs dendritic cell function by intracellularly modulating actin cytoskeleton. These findings are published in the latest issue of iScience. read more
